Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · IEX Real-Time Price · USD
13.15
-0.01 (-0.08%)
At close: May 1, 2024, 4:00 PM
13.56
+0.41 (3.12%)
After-hours: May 1, 2024, 7:04 PM EDT
Elanco Animal Health Revenue
In the year 2023, Elanco Animal Health had annual revenue of $4.42B with 0.14% growth. Revenue in the quarter ending December 31, 2023 was $1.04B with 5.08% year-over-year growth.
Revenue (ttm)
$4.42B
Revenue Growth
+0.14%
P/S Ratio
1.47
Revenue / Employee
$450,714
Employees
9,800
Market Cap
6.50B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
| Dec 31, 2015 | 2.91B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.97B |
| Jazz Pharmaceuticals | 3.83B |
| The Ensign Group | 3.73B |
| Acadia Healthcare Company | 2.93B |
| Exelixis | 1.83B |
| Globus Medical | 1.57B |
| HealthEquity | 999.59M |
| Cytokinetics | 7.53M |
ELAN News
- 14 days ago - Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement - PRNewsWire
- 4 weeks ago - Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors - PRNewsWire
- 4 weeks ago - Activist investor Ancora secures two Elanco board seats, Bloomberg News reports - Reuters
- 2 months ago - Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary - PRNewsWire
- 2 months ago - Elanco Animal Health is Executing on Plan to Deliver for Shareholders - PRNewsWire
- 2 months ago - Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health - Business Wire
- 2 months ago - Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results - PRNewsWire
- 2 months ago - Elanco to Participate in Upcoming Investor Conferences - PRNewsWire